The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells

Gao,Huijie; Gao,Huijie; Fan,Hongxia; Fan,Hongxia; Xie,Hong; Xie,Hong

doi:10.3892/ijo.2023.5507

The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells

Authors:
- Huijie Gao
- Hongxia Fan
- Hong Xie
View Affiliations

Affiliations: Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, Tianjin 300070, P.R. China
Published online on: March 24, 2023 https://doi.org/10.3892/ijo.2023.5507
Article Number: 59
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer stem cells serve key roles in liver cancer recurrence and metastasis. Therefore, the present study evaluated novel regulators of stem cell factor expression to identify novel therapeutic strategies that could target liver cancer stem cells. Deep sequencing was performed to identify novel microRNAs (miRNAs) that were specifically altered in liver cancer tissues. The expression levels of stem cell markers were investigated by reverse transcription‑quantitative PCR and western blotting. Sphere formation assays and flow cytometry were used to assess tumor sphere‑forming ability and evaluate the population of cluster of differentiation 90⁺ cells. Tumor xenograft analyses were used to evaluate tumorigenicity, metastasis and stemness in vivo. Bioinformatics analyses and enhanced green fluorescent protein reporter assays or luciferase reporter assays were performed to identify the direct targets of miR‑HCC2 and its upstream transcription factors. MiR‑HCC2 strongly promoted the cancer stem cell‑like properties of liver cancer cells in vitro; it also contributed to tumorigenicity, metastasis and stemness in vivo. Bone morphogenic protein and activin membrane‑bound inhibitor homolog, a direct target of miR‑HCC2, activated the Wnt/β‑catenin signaling pathway to promote stemness in liver cancer cells. The transcription factor YY1 bound to the promoter of miR‑HCC2 and activated its transcription. The present study demonstrated the importance of miR‑HCC2 in the induction of stemness in liver cancer, providing new insights into liver cancer metastasis and recurrence.

View Figures

View References

1	El-Serag HB: Hepatocellular carcinoma. N Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
2	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
3	Yamashita T and Wang XW: Cancer stem cells in the development of liver cancer. J Clin Invest. 123:1911–1918. 2013. View Article : Google Scholar : PubMed/NCBI
4	Lee TK, Castilho A, Cheung VC, Tang KH, Ma S and Ng IO: CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell. 9:50–63. 2011. View Article : Google Scholar : PubMed/NCBI
5	Chan LH, Luk ST and Ma S: Turning hepatic cancer stem cells inside out-a deeper understanding through multiple perspectives. Mol Cells. 38:202–209. 2015. View Article : Google Scholar : PubMed/NCBI
6	Li XF, Chen C, Xiang DM, Qu L, Sun W, Lu XY, Zhou TF, Chen SZ, Ning BF, Cheng Z, et al: Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance. Hepatology. 66:1934–1951. 2017. View Article : Google Scholar : PubMed/NCBI
7	Sun C, Shui B, Zhao W, Liu H, Li W, Lee JC, Doran R, Lee FK, Sun T, Shen QS, et al: Central role of IP3R2-mediated Ca(2+) oscillation in self-renewal of liver cancer stem cells elucidated by high-signal ER sensor. Cell Death Dis. 10:3962019. View Article : Google Scholar
8	Toraih EA, Fawzy MS, El-Falouji AI, Hamed EO, Nemr NA, Hussein MH and Abd El Fadeal NM: Stemness-related transcriptional factors and homing gene expression profiles in hepatic differentiation and cancer. Mol Med. 22:653–663. 2016. View Article : Google Scholar : PubMed/NCBI
9	Villasante A, Piazzolla D, Li H, Gomez-Lopez G, Djabali M and Serrano M: Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells. Cell Cycle. 10:1488–1498. 2011. View Article : Google Scholar : PubMed/NCBI
10	Machida K, Chen CL, Liu JC, Kashiwabara C, Feldman D, French SW, Sher L, Hyeongnam JJ and Tsukamoto H: Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus. J Gastroenterol Hepatol. 27(Suppl 2): S19–S22. 2012. View Article : Google Scholar
11	Guo JC, Yang YJ, Zheng JF, Zhang JQ, Guo M, Yang X, Jiang XL, Xiang L, Li Y, Ping H and Zhuo L: Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells. Exp Mol Med. 51:1–20. 2019. View Article : Google Scholar : PubMed/NCBI
12	Moon JH, Kwon S, Jun EK, Kim A, Whang KY, Kim H, Oh S, Yoon BS and You S: Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells. Biochem Biophys Res Commun. 412:175–181. 2011. View Article : Google Scholar : PubMed/NCBI
13	Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, Guerra M, Guo W and Xu X: Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. 31:4898–4911. 2012. View Article : Google Scholar : PubMed/NCBI
14	Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT and Fan ST: Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 13:153–166. 2008. View Article : Google Scholar : PubMed/NCBI
15	Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009. View Article : Google Scholar : PubMed/NCBI
16	Esteller M: Non-coding RNAs in human disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
17	Kim M, Civin CI and Kingsbury TJ: MicroRNAs as regulators and effectors of hematopoietic transcription factors. Wiley Interdiscip Rev RNA. 10:e15372019. View Article : Google Scholar : PubMed/NCBI
18	Shi DM, Bian XY, Qin CD and Wu WZ: miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway. Onco Targets Ther. 11:571–585. 2018. View Article : Google Scholar : PubMed/NCBI
19	Zheng Z, Liu J, Yang Z, Wu L, Xie H, Jiang C, Lin B, Chen T, Xing C, Liu Z, et al: MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway. Oncotarget. 7:28000–28012. 2016. View Article : Google Scholar : PubMed/NCBI
20	Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massagué J and Niehrs C: Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature. 401:480–485. 1999. View Article : Google Scholar : PubMed/NCBI
21	Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y and Chen YG: Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem. 284:30097–30104. 2009. View Article : Google Scholar : PubMed/NCBI
22	Mai Y, Zhang Z, Yang H, Dong P, Chu G, Yang G and Sun S: BMP and activin membrane-bound inhibitor (BAMBI) inhibits the adipogenesis of porcine preadipocytes through Wnt/β-catenin signaling pathway. Biochem Cell Biol. 92:172–182. 2014. View Article : Google Scholar : PubMed/NCBI
23	Lin Z, Gao C, Ning Y, He X, Wu W and Chen YG: The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling. J Biol Chem. 283:33053–33058. 2008. View Article : Google Scholar : PubMed/NCBI
24	Zhang Q, Shi XE, Song C, Sun S, Yang G and Li X: BAMBI Promotes C2C12 myogenic differentiation by enhancing Wnt/β-Catenin signaling. Int J Mol Sci. 16:17734–17745. 2015. View Article : Google Scholar : PubMed/NCBI
25	Liu K, Song X, Ma H, Liu L, Wen X, Yu J, Wang L and Hu S: Knockdown of BAMBI inhibits β-catenin and transforming growth factor β to suppress metastasis of gastric cancer cells. Mol Med Rep. 10:874–880. 2014. View Article : Google Scholar : PubMed/NCBI
26	Tang T, Guo C, Xia T, Zhang R, Zen K, Pan Y and Jin L: LncCCAT1 promotes breast cancer stem cell function through activating WNT/β-catenin signaling. Theranostics. 9:7384–7402. 2019. View Article : Google Scholar :
27	Hoffmeyer K, Raggioli A, Rudloff S, Anton R, Hierholzer A, Del Valle I, Hein K, Vogt R and Kemler R: Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. Science. 336:1549–1554. 2012. View Article : Google Scholar : PubMed/NCBI
28	Lu J, Wei JH, Feng ZH, Chen ZH, Wang YQ, Huang Y, Fang Y, Liang YP, Cen JJ, Pan YH, et al: miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling. Oncotarget. 8:21461–21471. 2017. View Article : Google Scholar : PubMed/NCBI
29	Bentley DR: Whole-genome re-sequencing. Curr Opin Genet Dev. 16:545–552. 2006. View Article : Google Scholar : PubMed/NCBI
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
31	Edwards M, Wong SC, Chotpadiwetkul R, Smirlis D, Phillips IR and Shephard EA: Transfection of primary cultures of rat hepatocytes. Methods Mol Biol. 320:273–282. 2006.PubMed/NCBI
32	Yi J, Fan Y, Zhang L, Wang H, Mu T, Xie H, Gao H, Liu M, Li S and Tang H: MiR-HCC2 Up-regulates BAMBI and ELMO1 expression to facilitate the proliferation and EMT of hepatocellular carcinoma cells. J Cancer. 10:3407–3419. 2019. View Article : Google Scholar : PubMed/NCBI
33	Chen T, Dai X, Dai J, Ding C, Zhang Z, Lin Z, Hu J, Lu M, Wang Z, Qi Y, et al: AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death Dis. 11:8222020. View Article : Google Scholar : PubMed/NCBI
34	Saliminejad K, Khorram Khorshid HR, Soleymani Fard S and Ghaffari SH: An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 234:5451–5465. 2019. View Article : Google Scholar
35	Mani SK, Zhang H, Diab A, Pascuzzi PE, Lefrançois L, Fares N, Bancel B, Merle P and Andrisani O: EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes. J Hepatol. 65:888–898. 2016. View Article : Google Scholar : PubMed/NCBI
36	Nusse R: Wnt signaling and stem cell control. Cell Res. 18:523–527. 2008. View Article : Google Scholar : PubMed/NCBI
37	de Sousa E Melo F and Vermeulen L: Wnt signaling in cancer stem cell biology. Cancers (Basel). 8:602016. View Article : Google Scholar : PubMed/NCBI
38	Shaikh MV, Kala M and Nivsarkar M: CD90 a potential cancer stem cell marker and a therapeutic target. Cancer Biomark. 16:301–307. 2016. View Article : Google Scholar : PubMed/NCBI
39	Shangguan L, Ti X, Krause U, Hai B, Zhao Y, Yang Z and Liu F: Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Stem Cells. 30:2810–2819. 2012. View Article : Google Scholar : PubMed/NCBI
40	Jho EH, Zhang T, Domon C, Joo CK, Freund JN and Costantini F: Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 22:1172–1183. 2002. View Article : Google Scholar : PubMed/NCBI
41	Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR and Fearon ER: Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem. 277:21657–21665. 2002. View Article : Google Scholar : PubMed/NCBI
42	Zhang L, Shi S, Zhang J, Zhou F and ten Dijke P: Wnt/β-catenin signaling changes C2C12 myoblast proliferation and differentiation by inducing Id3 expression. Biochem Biophys Res Commun. 419:83–88. 2012. View Article : Google Scholar : PubMed/NCBI
43	Zhu K, Li J, Sun J, Sun J, Guo Y, Tian H, Li L, Zhang C, Shi M, Kong G and Li Z: Ring1 promotes the transformation of hepatic progenitor cells into cancer stem cells through the Wnt/β-catenin signaling pathway. J Cell Biochem. 121:3941–3951. 2020. View Article : Google Scholar
44	Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, et al: NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell. 14:369–381. 2008. View Article : Google Scholar : PubMed/NCBI
45	Tsang DP, Wu WK, Kang W, Lee YY, Wu F, Yu Z, Xiong L, Chan AW, Tong JH, Yang W, et al: Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. J Pathol. 238:651–664. 2016. View Article : Google Scholar : PubMed/NCBI
46	Austen M, Cerni C, Luscher-Firzlaff JM and Luscher B: YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc. Oncogene. 17:511–520. 1998. View Article : Google Scholar : PubMed/NCBI